Mathes Company, Inc. Gilead Sciences, Inc. Transaction History

Mathes Company, Inc.

$275 Million
Q2 2024

A detailed history of Mathes Company, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mathes Company, Inc. holds 6,500 shares of GILD stock, worth $544,830. This represents 0.16% of its overall portfolio holdings.

Number of Shares

6,500

Previous 7,000 7.14%

Holding current value

$544,830

Previous $513,000 13.06%

% of portfolio

0.16%

Previous 0.19%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $31,575 - $36,440	-500 Reduced 7.14%	6,500 $446,000
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $74,109 - $84,532	-975 Reduced 12.23%	7,000 $539,000
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $81,100 - $92,050	-1,250 Reduced 13.55%	7,975 $579,000
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $65,056 - $71,083	-1,025 Reduced 10.0%	9,225 $635,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $105,000 - $119,804	1,750 Added 20.59%	10,250 $662,000
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $126,595 - $147,000	-1,750 Reduced 17.07%	8,500 $654,000
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $78,287 - $100,275	-1,250 Reduced 10.87%	10,250 $766,000
Q4 2019 Jan 30, 2020	SELL	$61.62 - $67.78 $61,620 - $67,780	-1,000 Reduced 8.0%	11,500 $747,000
Q2 2019 Jul 29, 2019	SELL	$61.87 - $69.38 $10,827 - $12,141	-175 Reduced 1.38%	12,500 $845,000
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $37,518 - $42,030	-600 Reduced 4.52%	12,675 $824,000
Q4 2018 Jan 29, 2019	SELL	$60.54 - $79.0 $54,486 - $71,100	-900 Reduced 6.35%	13,275 $830,000
Q3 2018 Oct 31, 2018	BUY	$71.28 - $78.92 $7,128 - $7,892	100 Added 0.71%	14,175 $1.09 Million
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $35,684 - $41,624	-550 Reduced 3.76%	14,075 $997,000
Q4 2017 Jan 19, 2018	SELL	$71.15 - $83.52 $305,945 - $359,136	-4,300 Reduced 22.72%	14,625 $1.05 Million
Q3 2017 Oct 20, 2017	BUY	$72.11 - $85.47 $1.36 Million - $1.62 Million	18,925	18,925 $1.53 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mathes Company, Inc. with notifications on news.

Account

Mathes Company, Inc. Gilead Sciences, Inc. Transaction History